Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 25 items for :

  • "high-grade" x
  • Refine by access: Open Access content only x
Clear All
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close
,
Oleksii Nikolaienko K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Oleksii Nikolaienko in
Google Scholar
PubMed Close
,
Wei Deng K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Wei Deng in
Google Scholar
PubMed Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed Close
,
Anne Couvelard Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St.Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed Close
,
Merete Krogh Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Merete Krogh in
Google Scholar
PubMed Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed Close

Introduction High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are defined by the presence of neuroendocrine phenotype and a high proliferation rate (Ki-67 > 20%). The HG NEN entity consists of well

Article Type:
Research Article
Collections:
Top-cited articles of 2023
DOI:
https://doi.org/10.1530/ERC-21-0152
Volume/Issue:
Volume 29: Issue 1
Open access
Jennifer R Eads Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Pennsylvania, USA

Search for other papers by Jennifer R Eads in
Google Scholar
PubMed Close
,
Thorvardur R Halfdanarson Division of Medical Oncology, Mayo Clinic Cancer Center, Rochester, Minnesota, USA

Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed Close
,
Tim Asmis Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada

Search for other papers by Tim Asmis in
Google Scholar
PubMed Close
,
Andrew M Bellizzi Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA

Search for other papers by Andrew M Bellizzi in
Google Scholar
PubMed Close
,
Emily K Bergsland Department of Medicine, University of California, San Francisco, California, USA

Search for other papers by Emily K Bergsland in
Google Scholar
PubMed Close
,
Arvind Dasari Division of Gastrointestinal Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Arvind Dasari in
Google Scholar
PubMed Close
,
Ghassan El-Haddad Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Search for other papers by Ghassan El-Haddad in
Google Scholar
PubMed Close
,
Michael Frumovitz Division of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Michael Frumovitz in
Google Scholar
PubMed Close
,
Joshua Meyer Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Search for other papers by Joshua Meyer in
Google Scholar
PubMed Close
,
Erik Mittra Division of Molecular Imaging and Therapy, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Erik Mittra in
Google Scholar
PubMed Close
,
Sten Myrehaug Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Search for other papers by Sten Myrehaug in
Google Scholar
PubMed Close
,
Eric Nakakura Department of Surgery, University of California, San Francisco, California, USA

Search for other papers by Eric Nakakura in
Google Scholar
PubMed Close
,
Nitya Raj Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Nitya Raj in
Google Scholar
PubMed Close
,
Heloisa P Soares Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Salt Lake City, Utah, USA

Search for other papers by Heloisa P Soares in
Google Scholar
PubMed Close
,
Brian Untch Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Brian Untch in
Google Scholar
PubMed Close
,
Namrata Vijayvergia Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Search for other papers by Namrata Vijayvergia in
Google Scholar
PubMed Close
, and
Jennifer A Chan Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jennifer A Chan in
Google Scholar
PubMed Close

Introduction High-grade neuroendocrine neoplasms (NENs) constitute a rare disease entity and account for approximately 10% of all NENs. Given their rarity, there is a paucity of prospective data to guide the optimal diagnosis and management of

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-22-0206
Volume/Issue:
Volume 30: Issue 8
Open access
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed Close
,
Aurel Perren Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed Close
,
Anne Couvelard Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St. Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed Close
,
Lene W Vestermark Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Lene W Vestermark in
Google Scholar
PubMed Close
,
Morten Ladekarl Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Morten Ladekarl in
Google Scholar
PubMed Close
,
Elizaveta Mitkina Tabaksblat Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Elizaveta Mitkina Tabaksblat in
Google Scholar
PubMed Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed Close

Introduction Neuroendocrine neoplasms (NENs) constitute ~2% of all malignancies and are frequently located in the gastrointestinal (GI) tract and pancreas. High-grade gastroenteropancreatic (HG-GEP) NENs are among the most aggressive cancers

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0057
Volume/Issue:
Volume 30: Issue 10
Open access
Alicia A Tone The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Alicia A Tone in
Google Scholar
PubMed Close
,
Carl Virtanen The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Carl Virtanen in
Google Scholar
PubMed Close
,
Patricia A Shaw The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Patricia A Shaw in
Google Scholar
PubMed Close
, and
Theodore J Brown The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Theodore J Brown in
Google Scholar
PubMed Close

epithelium (OSE), accumulating evidence provides strong support that high-grade serous adnexal cancer, commonly attributed to an ovarian origin, arises from the distal fallopian tube epithelium (FTE; Colgan et al . 2001 , Piek et al . 2001 , Finch et al

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-10-0235
Volume/Issue:
Volume 18: Issue 2
Open access
View license
Catherine T Choy Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Catherine T Choy in
Google Scholar
PubMed Close
,
Haseong Kim Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Haseong Kim in
Google Scholar
PubMed Close
,
Ji-Young Lee Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Ji-Young Lee in
Google Scholar
PubMed Close
,
David M Williams Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by David M Williams in
Google Scholar
PubMed Close
,
David Palethorpe Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by David Palethorpe in
Google Scholar
PubMed Close
,
Greg Fellows Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Greg Fellows in
Google Scholar
PubMed Close
,
Alan J Wright Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Alan J Wright in
Google Scholar
PubMed Close
,
Ken Laing Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Ken Laing in
Google Scholar
PubMed Close
,
Leslie R Bridges Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Leslie R Bridges in
Google Scholar
PubMed Close
,
Franklyn A Howe Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Franklyn A Howe in
Google Scholar
PubMed Close
, and
Soo-Hyun Kim Division of Biomedical Sciences, Academic Neurosurgery Unit, Division of Clinical Sciences, Department of Cellular Pathology, Division of Cardiac and Vascular Sciences, Department of Electrical and Electronic Engineering, St George's Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK

Search for other papers by Soo-Hyun Kim in
Google Scholar
PubMed Close

that KAL1 was differentially expressed according to the grade and type of tumor, showing an upregulation in high-grade primary brain tumors. We also found that anosmin-1 enhanced proliferation and motility of glioblastoma cells in vitro , formed a

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-13-0181
Volume/Issue:
Volume 21: Issue 1
Open access
Takeshi Ujike Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Takeshi Ujike in
Google Scholar
PubMed Close
,
Motohide Uemura Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Department of Therapeutic Urologic Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Motohide Uemura in
Google Scholar
PubMed Close
,
Atsunari Kawashima Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Atsunari Kawashima in
Google Scholar
PubMed Close
,
Akira Nagahara Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Akira Nagahara in
Google Scholar
PubMed Close
,
Kazutoshi Fujita Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Kazutoshi Fujita in
Google Scholar
PubMed Close
,
Yasushi Miyagawa Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Yasushi Miyagawa in
Google Scholar
PubMed Close
, and
Norio Nonomura Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Search for other papers by Norio Nonomura in
Google Scholar
PubMed Close

examining 354 patients undergoing robot-assisted prostatectomy, they concluded that low FT levels were linked with high-grade prostate cancer. In total, the relationship between prostate cancer risk and absolute androgen concentration remain controversial

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-17-0134
Volume/Issue:
Volume 25: Issue 1
Open access
Jonathan R Strosberg Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Jonathan R Strosberg in
Google Scholar
PubMed Close
,
James C Yao Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by James C Yao in
Google Scholar
PubMed Close
,
Emilio Bajetta Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Emilio Bajetta in
Google Scholar
PubMed Close
,
Mounir Aout Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Mounir Aout in
Google Scholar
PubMed Close
,
Bert Bakker Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Bert Bakker in
Google Scholar
PubMed Close
,
John D Hainsworth Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by John D Hainsworth in
Google Scholar
PubMed Close
,
Philippe B Ruszniewski Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Philippe B Ruszniewski in
Google Scholar
PubMed Close
,
Eric Van Cutsem Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Eric Van Cutsem in
Google Scholar
PubMed Close
,
Kjell Öberg Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Kjell Öberg in
Google Scholar
PubMed Close
, and
Marianne E Pavel Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Marianne E Pavel in
Google Scholar
PubMed Close

differentiated or high-grade NET were not eligible. Furthermore, patients were ineligible if they had received cytotoxic chemotherapy, immunotherapy, or radiotherapy within 4 weeks prior to randomization, or prior therapy with mammalian target of rapamycin

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-15-0314
Volume/Issue:
Volume 22: Issue 6
Open access
Siker Kimbung Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Sweden

Search for other papers by Siker Kimbung in
Google Scholar
PubMed Close
,
Ching-yi Chang Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA

Search for other papers by Ching-yi Chang in
Google Scholar
PubMed Close
,
Pär-Ola Bendahl Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Sweden

Search for other papers by Pär-Ola Bendahl in
Google Scholar
PubMed Close
,
Laura Dubois Duke Proteomics and Metabolomics Resource, Duke University School of Medicine, Durham, NC, USA

Search for other papers by Laura Dubois in
Google Scholar
PubMed Close
,
J Will Thompson Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA
Duke Proteomics and Metabolomics Resource, Duke University School of Medicine, Durham, NC, USA

Search for other papers by J Will Thompson in
Google Scholar
PubMed Close
,
Donald P McDonnell Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA

Search for other papers by Donald P McDonnell in
Google Scholar
PubMed Close
, and
Signe Borgquist Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Sweden
Clinical Trial Unit, Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden

Search for other papers by Signe Borgquist in
Google Scholar
PubMed Close

seen among high-grade tumors ( Nelson et al. 2013 ). In addition, the concentration of 27HC was found to be higher in ERα-positive breast tumors compared to normal breast tissue, and this was attributed to a corresponding decrease in the expression of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0533
Volume/Issue:
Volume 24: Issue 7
Open access
Maria Angela De Stefano Department of Public Health, University of Naples “Federico II”, Naples, Italy

Search for other papers by Maria Angela De Stefano in
Google Scholar
PubMed Close
,
Tommaso Porcelli Department of Public Health, University of Naples “Federico II”, Naples, Italy

Search for other papers by Tommaso Porcelli in
Google Scholar
PubMed Close
,
Martin Schlumberger Department of Endocrine Oncology, Gustave Roussy and University Paris-Saclay, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
, and
Domenico Salvatore Department of Public Health, University of Naples “Federico II”, Naples, Italy
CEINGE Biotecnologie Avanzate Scarl, Naples, Italy

Search for other papers by Domenico Salvatore in
Google Scholar
PubMed Close

et al. 2012 ), we showed that D3 is dramatically downregulated at later phases of tumorigenesis and that the expression of D2 is upregulated in high-grade squamous cell carcinoma. High D2 expression levels have also been found in other advanced

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-23-0015
Volume/Issue:
Volume 30: Issue 5
Open access
Sara Pusceddu Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Search for other papers by Sara Pusceddu in
Google Scholar
PubMed Close
,
Francesco Barretta Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Francesco Barretta in
Google Scholar
PubMed Close
,
Annalisa Trama Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Evaluative Epidemiology Unit, ENETS Center of Excellence, Milan, Italy

Search for other papers by Annalisa Trama in
Google Scholar
PubMed Close
,
Laura Botta Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Evaluative Epidemiology Unit, ENETS Center of Excellence, Milan, Italy

Search for other papers by Laura Botta in
Google Scholar
PubMed Close
,
Massimo Milione Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Massimo Milione in
Google Scholar
PubMed Close
,
Roberto Buzzoni Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Search for other papers by Roberto Buzzoni in
Google Scholar
PubMed Close
,
Filippo De Braud Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
University of Milan, Milan, Italy

Search for other papers by Filippo De Braud in
Google Scholar
PubMed Close
,
Vincenzo Mazzaferro University of Milan, Milan, Italy
Liver Surgery, Transplantation and Gastroenterology, University of Milan and Istituto Nazionale Tumori Fondazione IRCCS, ENETS Center of Excellence, Milano, Milan, Italy

Search for other papers by Vincenzo Mazzaferro in
Google Scholar
PubMed Close
,
Ugo Pastorino Department of Thoracic Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Ugo Pastorino in
Google Scholar
PubMed Close
,
Ettore Seregni Department of Nuclear Medicine ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milan, Italy

Search for other papers by Ettore Seregni in
Google Scholar
PubMed Close
,
Luigi Mariani Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Luigi Mariani in
Google Scholar
PubMed Close
,
Gemma Gatta Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Evaluative Epidemiology Unit, ENETS Center of Excellence, Milan, Italy

Search for other papers by Gemma Gatta in
Google Scholar
PubMed Close
,
Maria Di Bartolomeo Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Search for other papers by Maria Di Bartolomeo in
Google Scholar
PubMed Close
,
Daniela Femia Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Search for other papers by Daniela Femia in
Google Scholar
PubMed Close
,
Natalie Prinzi Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Search for other papers by Natalie Prinzi in
Google Scholar
PubMed Close
,
Jorgelina Coppa Liver Surgery, Transplantation and Gastroenterology, University of Milan and Istituto Nazionale Tumori Fondazione IRCCS, ENETS Center of Excellence, Milano, Milan, Italy

Search for other papers by Jorgelina Coppa in
Google Scholar
PubMed Close
,
Francesco Panzuto Department of Medical Gastroenterology, Azienda Ospedaliera Sant’Andrea, Roma ENETS Center of Excellence, Rome, Italy

Search for other papers by Francesco Panzuto in
Google Scholar
PubMed Close
,
Lorenzo Antonuzzo Department of Medical Oncology, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

Search for other papers by Lorenzo Antonuzzo in
Google Scholar
PubMed Close
,
Emilio Bajetta Department of Medical Oncology, Policlinico di Monza, Monza, Italy

Search for other papers by Emilio Bajetta in
Google Scholar
PubMed Close
,
Maria Pia Brizzi Department of Medical Oncology, Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy

Search for other papers by Maria Pia Brizzi in
Google Scholar
PubMed Close
,
Davide Campana Department of Medical Oncology, Policlinico Sant’Orsola Malpighi, Bologna, Italy

Search for other papers by Davide Campana in
Google Scholar
PubMed Close
,
Laura Catena Department of Medical Oncology, Policlinico di Monza, Monza, Italy

Search for other papers by Laura Catena in
Google Scholar
PubMed Close
,
Harry Comber Ireland National Cancer Registry, Cork, Ireland

Search for other papers by Harry Comber in
Google Scholar
PubMed Close
,
Fiona Dwane Ireland National Cancer Registry, Cork, Ireland

Search for other papers by Fiona Dwane in
Google Scholar
PubMed Close
,
Nicola Fazio Department of Medical Oncology, IEO – Istituto Europeo di Oncologia, Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed Close
,
Antongiulio Faggiano Department of Thyroid and Parathyroid Surgery Unit, Azienda Ospedaliera Universitaria Federico II, ENETS Center of Excellence, Naples, Italy

Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed Close
,
Dario Giuffrida Department of Medical Oncology, IOM – Istituto Oncologico del Mediterraneo, Catania, Italy

Search for other papers by Dario Giuffrida in
Google Scholar
PubMed Close
,
Kris Henau Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Kris Henau in
Google Scholar
PubMed Close
,
Toni Ibrahim Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST, IRCCS, Meldola, Italy

Search for other papers by Toni Ibrahim in
Google Scholar
PubMed Close
,
Riccardo Marconcini Department of Medical Oncology, Ospedale Santa Chiara, Pisa, Italy

Search for other papers by Riccardo Marconcini in
Google Scholar
PubMed Close
,
Sara Massironi Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy

Search for other papers by Sara Massironi in
Google Scholar
PubMed Close
,
Maja Primic Žakelj Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Ljubljana, Slovenia

Search for other papers by Maja Primic Žakelj in
Google Scholar
PubMed Close
,
Francesca Spada Department of Medical Oncology, IEO – Istituto Europeo di Oncologia, Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Francesca Spada in
Google Scholar
PubMed Close
,
Salvatore Tafuto Department of Medical Oncology, Fondazione IRCCS Pascale, ENETS Center of Excellence, Naples, Italy

Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed Close
,
Elizabeth Van Eycken Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Elizabeth Van Eycken in
Google Scholar
PubMed Close
,
Jan Maaten Van der Zwan Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

Search for other papers by Jan Maaten Van der Zwan in
Google Scholar
PubMed Close
,
Tina Žagar Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Ljubljana, Slovenia

Search for other papers by Tina Žagar in
Google Scholar
PubMed Close
,
Luca Giacomelli Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy

Search for other papers by Luca Giacomelli in
Google Scholar
PubMed Close
,
Rosalba Miceli Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy

Search for other papers by Rosalba Miceli in
Google Scholar
PubMed Close
, and
NEPscore Working Group
Search for other papers by NEPscore Working Group in
Google Scholar
PubMed Close

scores for OS have been specifically developed to assess OS in patients with gut NETs ( Modlin et al . 2010 ) or gastrointestinal high-grade, G3 neuroendocrine carcinomas (GI-NECs) ( Lamarca et al . 2017 ), to predict progression-free survival of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-17-0489
Volume/Issue:
Volume 25: Issue 6
Open access